Acadia Healthcare Q4 net loss $13.02/sh on $996M goodwill impairment; appoints new CEO

Acadia Healthcare Company, Inc.

2025-FY EPS reported -$12.16 revenue$3,312,769,000

Q4 revenue $821.5M (+6.1% YoY); net loss $13.02/diluted share from $996.2M goodwill impairment.
Adjusted EBITDA $99.8M (down 35% YoY) includes $52.7M PLGL reserve adjustment.
FY 2025 adjusted EPS $2.00 vs $3.30; FY 2026 guidance: rev $3.37-3.45B, adj EPS $1.30-1.55.
Debbie Osteen appointed CEO; full-year 2025 added 1,089 licensed beds.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.